From: The impact of preoperative immunonutritional status on postoperative complications in ovarian cancer
Variables | OR (95% CI) | P value |
---|---|---|
Age (years) | Â | Â |
   ≤ 53 | Ref. |  |
   > 53 | 1.38 (1.00, 1.92) | 0.049 |
NLR | Â | Â |
   ≤ 2.46 | Ref. |  |
   > 2.46 | 1.76 (1.27, 2.44) | < 0.001 |
PLR | Â | Â |
   ≤ 227.52 | Ref. |  |
   > 227.52 | 2.18 (1.53, 3.12) | < 0.001 |
LMR | Â | Â |
   ≤ 3.70 | Ref. |  |
   > 3.70 | 0.38 (0.27, 0.53) | < 0.001 |
TCLR | Â | Â |
   ≤ 3.39 | Ref. |  |
   > 3.39 | 1.59 (1.13, 2.23) | 0.008 |
FLR | Â | Â |
   ≤ 2.64 | Ref. |  |
   > 2.64 | 2.04 (1.47, 2.83) | < 0.001 |
FAR | Â | Â |
   ≤ 10.77 | Ref. |  |
   > 10.77 | 2.81 (1.98, 3.99) | < 0.001 |
SII | Â | Â |
   ≤ 818.23 | Ref. |  |
   > 818.23 | 1.96 (1.41, 2.74) | < 0.001 |
PNI | Â | Â |
   ≤ 46.73 | Ref. |  |
   > 46.73 | 0.29 (0.21, 0.41) | < 0.001 |
CONUT | Â | Â |
   ≤ 4 | Ref. |  |
   > 4 | 2.50 (1.65, 3.78) | < 0.001 |
RBC (10^12/L) | Â | Â |
   < 3.5 | Ref. |  |
   ≥ 3.5 | 0.31 (0.14, 0.67) | 0.003 |
Hb (g/L) | Â | Â |
   < 120 | Ref. |  |
   ≥ 120 | 0.54 (0.39, 0.75) | < 0.001 |
FIGO stage | Â | Â |
   I | Ref. |  |
   II | 1.04 (0.60, 1.80) | 0.899 |
   III | 1.98 (1.30, 3.02) | 0.001 |
   IV | 3.18 (1.58, 6.38) | 0.001 |
Ascites | Â | Â |
   No | Ref. |  |
   Yes | 2.12 (1.48, 3.03) | < 0.001 |
Hydrothorax | Â | Â |
   No | Ref. |  |
   Yes | 3.76 (1.99, 7.12) | < 0.001 |
Surgery methods | Â | Â |
   Laparotomy | Ref. |  |
   Laparoscopy | 0.49 (0.33, 0.72) | < 0.001 |
Upper abdominal surgery | Â | Â |
   No | Ref. |  |
   Yes | 3.71 (1.27, 10.82) | 0.016 |
Enterectomy | Â | Â |
   No | Ref. |  |
   Yes | 2.94 (1.71, 5.05) | < 0.001 |
Lymphadenectomy | Â | Â |
   No | Ref. |  |
   Yes | 0.90 (0.66, 1.22) | 0.498 |
Lymph node metastasis | Â | Â |
   Negative | Ref. |  |
   Positive | 2.01 (1.34, 3.01) | < 0.001 |
Residue | Â | Â |
   No residual disease | Ref. |  |
   ≤ 1 cm | 1.85 (1.26, 2.71) | 0.002 |
   > 1 cm | 1.47 (0.95, 2.26) | 0.081 |